Related Experiment Video
Updated: Aug 12, 2026

Isolation of Double Negative αβ T Cells from the Kidney
Published on: May 16, 2014
The pathogenic role of double-negative B cells in autoimmune diseases
Yanzuo Wu1, Ze Yang1, Shuo Huang2
1The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Abstract:
Double-negative (DN) B cells have emerged as pivotal players in autoimmune diseases, transitioning from an overlooked exhausted subpopulation to a lineage with potent pathogenic potential. Based on surface marker expression, DN B cells are subdivided into four distinct subsets: DN1, DN2, DN3, and DN4. This review provides a comprehensive overview of these subsets, focusing on their origins, phenotypes, and developmental trajectories. In disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), primary Sjögren's syndrome (pSS), and multiple sclerosis (MS), expanded DN B cells infiltrate target organs via chemokine receptor-mediated pathways and interact with T cells to drive the pathological remodeling of the local immune microenvironment. Elucidating the regulatory mechanisms of DN B cell differentiation and their functional heterogeneity across disease contexts will provide a critical foundation for the development of targeted precision immunotherapies.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
What is the Immune System?
Type I Diabetes I: Introduction

